Dyne Therapeutics, Inc.
corporate_fare Company Profile
Dyne Therapeutics, Inc. (NASDAQ:DYN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 44 items for DYN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Dyne Therapeutics Expands Debt Facility to $400M, Borrows $50M Immediately
- Dyne Therapeutics Expands Debt Facility to $400M, Securing $50M Immediately
- Shareholders Approve Doubling Authorized Shares to 400M, Enabling Future Capital Raises
- Dyne Therapeutics Completes Enrollment for Key DM1 Trial, Sets Q1 2027 Data Target
- Dyne Therapeutics Completes Enrollment for Registrational DM1 Trial, Topline Data Expected Q1 2027
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$446.21M
Diluted EPS
-$3.47
Op. Cash Flow
-$403.21M
Free Cash Flow
-$405.13M
Operating Income
-$468.18M
Cash & Equivalents
$893.37M
Total Debt
$148.92M
Debt / Equity
0.15×
Shares Outstanding
164.95M sh
Source: 10-K · filed 2026-03-02 · accession 0001193125-26-084178
show_chartPrice Chart
Loading chart...
feed DYN - Filings & News (Page 2)
DYN
Jun 17, 2026, 7:35 AM EDT
Price at Filing:
$18.75
Real-time Price:
$15.50
Change:
-$3.25 (-17%)
Market Cap:
$2.904B
DYN
Jun 17, 2026, 7:30 AM EDT
Price at Filing:
$18.75
Real-time Price:
$15.50
Change:
-$3.25 (-17%)
Market Cap:
$2.904B
DYN
Jun 08, 2026, 4:05 PM EDT
Price at Filing:
$16.81
Real-time Price:
$15.50
Change:
-$1.31 (-8%)
Market Cap:
$2.904B
DYN
Jun 03, 2026, 7:35 AM EDT
Price at Filing:
$18.37
Real-time Price:
$15.50
Change:
-$2.87 (-16%)
Market Cap:
$2.904B
DYN
Jun 03, 2026, 7:30 AM EDT
Price at Filing:
$18.37
Real-time Price:
$15.50
Change:
-$2.87 (-16%)
Market Cap:
$2.904B
DYN
May 26, 2026, 7:30 AM EDT
Price at Filing:
$17.50
Real-time Price:
$15.50
Change:
-$2.00 (-11%)
Market Cap:
$2.904B
DYN
May 21, 2026, 3:14 AM EDT
Price at Filing:
$18.76
Real-time Price:
$15.50
Change:
-$3.26 (-17%)
Market Cap:
$2.904B
DYN
May 11, 2026, 7:35 AM EDT
Price at Filing:
$17.60
Real-time Price:
$15.50
Change:
-$2.10 (-12%)
Market Cap:
$2.904B
DYN
May 11, 2026, 7:31 AM EDT
Price at Filing:
$17.60
Real-time Price:
$15.50
Change:
-$2.10 (-12%)
Market Cap:
$2.904B
DYN
May 11, 2026, 7:25 AM EDT
Price at Filing:
$17.43
Real-time Price:
$15.50
Change:
-$1.93 (-11%)
Market Cap:
$2.904B
DYN
May 06, 2026, 4:43 PM EDT
Price at Filing:
$18.84
Real-time Price:
$15.50
Change:
-$3.34 (-18%)
Market Cap:
$2.904B
DYN
May 05, 2026, 4:39 PM EDT
Price at Filing:
$17.47
Real-time Price:
$15.50
Change:
-$1.97 (-11%)
Market Cap:
$2.904B
DYN
Apr 28, 2026, 4:42 PM EDT
Price at Filing:
$18.16
Real-time Price:
$15.50
Change:
-$2.66 (-15%)
Market Cap:
$2.904B
DYN
Apr 27, 2026, 4:34 PM EDT
Price at Filing:
$18.04
Real-time Price:
$15.50
Change:
-$2.54 (-14%)
Market Cap:
$2.904B
DYN
Apr 24, 2026, 4:46 PM EDT
Price at Filing:
$18.26
Real-time Price:
$15.50
Change:
-$2.76 (-15%)
Market Cap:
$2.904B
DYN
Apr 23, 2026, 4:05 PM EDT
Dyne Therapeutics Seeks Shareholder Approval to Double Authorized Common Stock to 400 Million Shares
Price at Filing:
$18.90
Real-time Price:
$15.50
Change:
-$3.40 (-18%)
Market Cap:
$2.904B
DYN
Apr 21, 2026, 4:53 PM EDT
Price at Filing:
$19.21
Real-time Price:
$15.50
Change:
-$3.71 (-19%)
Market Cap:
$2.904B
DYN
Apr 09, 2026, 4:29 PM EDT
Price at Filing:
$19.36
Real-time Price:
$15.50
Change:
-$3.86 (-20%)
Market Cap:
$2.904B
DYN
Apr 01, 2026, 7:30 AM EDT
Price at Filing:
$18.13
Real-time Price:
$15.50
Change:
-$2.63 (-15%)
Market Cap:
$2.904B
DYN
Mar 11, 2026, 4:05 PM EDT
Price at Filing:
$20.00
Real-time Price:
$15.50
Change:
-$4.50 (-23%)
Market Cap:
$2.904B